360 related articles for article (PubMed ID: 33923525)
1. The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights.
Federico A; Rosato V; Masarone M; Torre P; Dallio M; Romeo M; Persico M
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33923525
[TBL] [Abstract][Full Text] [Related]
2. Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis.
DiStefano JK
Cell Mol Life Sci; 2020 Jun; 77(11):2079-2090. PubMed ID: 31760464
[TBL] [Abstract][Full Text] [Related]
3. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.
Ter Horst KW; Serlie MJ
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878197
[TBL] [Abstract][Full Text] [Related]
4. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
Jensen T; Abdelmalek MF; Sullivan S; Nadeau KJ; Green M; Roncal C; Nakagawa T; Kuwabara M; Sato Y; Kang DH; Tolan DR; Sanchez-Lozada LG; Rosen HR; Lanaspa MA; Diehl AM; Johnson RJ
J Hepatol; 2018 May; 68(5):1063-1075. PubMed ID: 29408694
[TBL] [Abstract][Full Text] [Related]
5. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
6. Dietary carbohydrates and fatty liver disease: de novo lipogenesis.
Chiu S; Mulligan K; Schwarz JM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):277-282. PubMed ID: 29697539
[TBL] [Abstract][Full Text] [Related]
7. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
[TBL] [Abstract][Full Text] [Related]
8. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
Softic S; Cohen DE; Kahn CR
Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
[TBL] [Abstract][Full Text] [Related]
9. Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism.
Jegatheesan P; De Bandt JP
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273805
[TBL] [Abstract][Full Text] [Related]
10. Effects of dietary sugar restriction on hepatic fat in youth with obesity.
Distefano JK; Gerhard GS
Minerva Pediatr (Torino); 2024 Jun; 76(3):439-448. PubMed ID: 37284808
[TBL] [Abstract][Full Text] [Related]
11. The relationship between excessive dietary fructose consumption and paediatric fatty liver disease.
DiStefano JK; Shaibi GQ
Pediatr Obes; 2021 Jun; 16(6):e12759. PubMed ID: 33305889
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans.
Pafili K; Roden M
Mol Metab; 2021 Aug; 50():101122. PubMed ID: 33220492
[TBL] [Abstract][Full Text] [Related]
13. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.
Moore JB; Gunn PJ; Fielding BA
Nutrients; 2014 Dec; 6(12):5679-703. PubMed ID: 25514388
[TBL] [Abstract][Full Text] [Related]
14. Fructose and hepatic insulin resistance.
Softic S; Stanhope KL; Boucher J; Divanovic S; Lanaspa MA; Johnson RJ; Kahn CR
Crit Rev Clin Lab Sci; 2020 Aug; 57(5):308-322. PubMed ID: 31935149
[TBL] [Abstract][Full Text] [Related]
15. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling.
Softic S; Gupta MK; Wang GX; Fujisaka S; O'Neill BT; Rao TN; Willoughby J; Harbison C; Fitzgerald K; Ilkayeva O; Newgard CB; Cohen DE; Kahn CR
J Clin Invest; 2017 Nov; 127(11):4059-4074. PubMed ID: 28972537
[TBL] [Abstract][Full Text] [Related]
16. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
[TBL] [Abstract][Full Text] [Related]
17. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).
Alwahsh SM; Gebhardt R
Arch Toxicol; 2017 Apr; 91(4):1545-1563. PubMed ID: 27995280
[TBL] [Abstract][Full Text] [Related]
18. Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.
Vancells Lujan P; Viñas Esmel E; Sacanella Meseguer E
Nutrients; 2021 Apr; 13(5):. PubMed ID: 33923255
[TBL] [Abstract][Full Text] [Related]
19. Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial.
Geidl-Flueck B; Hochuli M; Németh Á; Eberl A; Derron N; Köfeler HC; Tappy L; Berneis K; Spinas GA; Gerber PA
J Hepatol; 2021 Jul; 75(1):46-54. PubMed ID: 33684506
[TBL] [Abstract][Full Text] [Related]
20. Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.
Svop Jensen V; Fledelius C; Max Wulff E; Lykkesfeldt J; Hvid H
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
